Wednesday, Jan 10, 2024 · SEC filings
What the smart money revealed on Jan 10
334 insider filings came in. We hid 81 planned (10b5-1) sellers and 185 people whose filings were routine, like grants and tax withholding.
Kayne Anderson Energy Infrastructure Fund (KYN) President James Baker bought $442K
50,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 8 checked quarters beat the typical stock 6 months later.
Opko Health (OPK) Chief Innovation Officer Gary Nabel bought $201K
216,184 shares on the open market. Not a grant or an option exercise.
Avid Bioservices (CDMO) Director Richard Hancock bought $202K
38,803 shares on the open market. Not a grant or an option exercise. Filed late: $202K of it was bought Dec 13. Form 4s are due 2 business days after a trade.
Cell MedX (STME) CEO David Jeffs bought $150K
15M shares on the open market. Not a grant or an option exercise. Filed late: $150K of it was bought Dec 29. Form 4s are due 2 business days after a trade.
CCC Intelligent Solutions (CCC) Director Christopher Egan sold $230M
Not marked as a planned 10b5-1 sale. Sold 8% of the shares they held directly. Still holds 263.75M shares.
DoorDash (DASH) Director Stanley Tang sold $18.4M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 80,608 shares directly.
Intuit (INTU) EVP Alex Balazs sold $2.38M
Not marked as a planned 10b5-1 sale. Sold 95% of the shares they held directly. Still holds 225 shares.
Show 15 more real buys
Show 19 more real sales
13F season
Holdings as of Dec 31, 2023 are due Feb 14
49 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Jan 4–10
Open-market buys by officers and directors, filed in the 7 days up to Jan 10.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.